Results 11 to 20 of about 8,068 (200)
Current Opinion in Rheumatology, 2002 Inclusion body myositis (IBM) is an inflammatory myopathy with distinctive clinicopathologic features. The etiology of IBM remains elusive. The immune-mediated basis for this disease has been challenged by evidence implicating a number of divergent etiologic factors.
Rabi, Tawil, Robert C, Griggs
openaire +4 more sources
Current Opinion in Rheumatology, 2011 Sporadic inclusion body myositis (sIBM) is a poorly understood immune and degenerative disease of skeletal muscle. Here, current opinion of the nature of this disease is summarized.Recent findings for sIBM include further characterization of muscle involvement through magnetic resonance imaging, the role of muscle as a host for immune cells, progress ...
Ivanidze, Jana +5 more
openaire +5 more sources
Genetics in inclusion body myositis [PDF]
Current Opinion in Rheumatology, 2017 Purpose of review To review the advances in our understanding of the genetics of inclusion body myositis (IBM) in the past year. Recent findings One large genetic association study focusing on immune-related genes in IBM has refined the association within the human leukocyte antigen
Rothwell, Simon +2 more
openaire +3 more sources
Sarcoidosis and inclusion body myositis [PDF]
Rheumatology, 2008 no abstract ...
VATTEMI, Gaetano Nicola +7 more
openaire +3 more sources
Dysphagia as the Presenting Symptom for Inclusion Body Myositis
Journal of Investigative Medicine High Impact Case Reports, 2021 Dysphagia can be one of the manifestations of inflammatory myopathies (IMs). In some patients, it can be one of the presenting symptoms or the only symptom.
Marcus Juan Esteban MD +3 more
doaj +1 more source
Biology of Sport, 2014 Inclusion body myositis is a rare idiopathic inflammatory myopathy that produces extreme muscle weakness. Blood flow restricted resistance training has been shown to improve muscle strength and muscle hypertrophy in inclusion body myositis.
A.R. Santos +7 more
doaj +1 more source
Rheumatology & Autoimmunity, 2023 Introduction Statin‐associated immune‐mediated necrotizing myositis (IMNM) is a rare but distinct idiopathic inflammatory myopathy (IIM) that requires early recognition and intervention to prevent irreversible muscle damage. It is typically characterized
Nicole Daver, Sara Tonini
doaj +1 more source
Inclusion body myositis: Update on the diagnostic and therapeutic landscape
Frontiers in Neurology, 2022 Inclusion body myositis (IBM) is a progressive muscle disease affecting patients over the age of 40, with distinctive clinical and histopathological features. The typical clinical phenotype is characterized by prominent involvement of deep finger flexors
Elie Naddaf
doaj +1 more source
Pembrolizumab on pre-existing inclusion body myositis: a case report
BMC Rheumatology, 2020 Background Cases of exacerbation of pre-existing neuromuscular diseases induced by immune checkpoint inhibitors (ICIs) have rarely been reported because patients with autoimmune diseases have generally been excluded from ICI therapy due to the increased ...
Naohiro Uchio +9 more
doaj +1 more source
Polymyositis and dermatomyositis: Disease spectrum and classification
Indian Journal of Dermatology, 2012 Muscle inflammation and weakness are the key features of idiopathic inflammatory myopathies (IIMs). In addition IIMs are frequently associated with cutaneous and pulmonary involvement. In clinical practice the three common inflammatory myopathies we come
Siba P Raychaudhuri, Anupam Mitra
doaj +1 more source